On the Treatment of a Patient with Ataxic Syndrome by Microdoses of Levo- and Carbo-Dopa. Post COVID Treatment

Authors

  • G. Tarro President of the T.&L. deBeaumont Bonelli Foundation for Cancer Research, Naples, Italy
  • D. Raiderman Treating Doctor of Biocorrection Medical Center Klain International Consulting LTD, Israele

DOI:

https://doi.org/10.14738/jbemi.95.13206

Keywords:

biocorrection, levo- and carbo-dopa, ataxic syndrome, cerebellar neuropathy, long COVID.

Abstract

The neurological evaluation and the report of the physioterapist are described for a patient who from 2018 was blocked by neurological status with different problems that concerned his different functions of the nervous systems on coordination and balance, motor exam and even speech, after the treatment with microdoses of Sinemet CR for two months. The satisfation is reported by the neurologist regarding the results on the patient recovery. Post COVID disorders are suggested to be treated with special indication for long COVID.

Downloads

Published

2022-10-08

How to Cite

Tarro, G., & Raiderman, D. (2022). On the Treatment of a Patient with Ataxic Syndrome by Microdoses of Levo- and Carbo-Dopa. Post COVID Treatment. British Journal of Healthcare and Medical Research, 9(5), 132–138. https://doi.org/10.14738/jbemi.95.13206

Issue

Vol. 9 No. 5 (2022): British Journal of Healthcare and Medical Research

Section

Original Articles

License

Copyright (c) 2022 G. Tarro, D. Raiderman

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.